{
  "@context": "https://tradecompliancerecords.com/schemas/v2/regulation.json",
  "schema_version": "2.2.0",
  "open_data": true,
  "ai_optimized": true,
  "slug": "us-fda-drug-import-requirements",
  "name": "US FDA Drug Import Requirements — 21 CFR Part 312",
  "authority": "US Food and Drug Administration (FDA)",
  "region": "North America",
  "cluster": "Pharmaceuticals",
  "wikidata_qid": "Q30",
  "wikidata_entity": "https://www.wikidata.org/wiki/Q30",
  "wikipedia_article": "https://en.wikipedia.org/wiki/Special:EntityPage/Q30",
  "official_source_url": "https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-312",
  "gov_entry_url": "https://www.fda.gov/drugs/drug-imports",
  "document_types": "Regulation",
  "key_obligations": "FDA registration; cGMP compliance; prior approval; import alert compliance",
  "enforcement_bodies": "US FDA, US Customs and Border Protection",
  "penalty_ranges": "Import refusal, seizure, criminal prosecution",
  "affected_hs_codes": "30",
  "mandatory_deadline": "Active",
  "applicability_scope": "Pharmaceutical drugs imported into the US",
  "cryptographic_integrity": {
    "sha256_hash": "95070d0a78ed2b4e47284dffdaea92e1217838898f46dfa78ad56fa7da956e4c",
    "hash_algorithm": "SHA-256",
    "status": "cryptographically_hardened",
    "source_document_verified": true,
    "provenance": "source_document",
    "provenance_note": "SHA-256 derived from an ingested source document.",
    "r2_key": "regulations/us-fda-drug-import-requirements/us-fda-drug-import-requirements.html",
    "pdf_url": "https://tcr-vault.tradecompliancerecords.com/regulations/us-fda-drug-import-requirements/us-fda-drug-import-requirements.html",
    "file_size_bytes": 10596,
    "version_date": "2026-06-06",
    "last_verified_at": "2026-06-06T03:00:53.426Z"
  },
  "operational_consequences": null,
  "logistical_liability_exposure": false,
  "verification_consensus_score": "100%",
  "verification_notes": null,
  "tcr_authority_page": "https://tradecompliancerecords.com/wiki/us-fda-drug-import-requirements",
  "created_at": "2026-05-20 19:29:00",
  "infographic_r2_key": null,
  "infographic_sha256_hash": null,
  "infographic_generated_at": null,
  "infographic_approved": 0,
  "origin_problem": "FACTUAL: 2008 Heparin contamination incident (81 deaths, US) exposed gaps in FDA oversight of imported pharmaceuticals.",
  "problem_statement": "HEADLINE: Imported pharmaceuticals lacked consistent safety oversight, risking public health.",
  "pre_regulation_status_quo": "FACTUAL: No mandatory FDA registration for foreign drug manufacturers. No cGMP compliance checks for imports.",
  "operational_pain_points": [
    "FDA registration process: avg 6-12 months for approval (FDA data 2023)",
    "cGMP compliance audits: required annually for all foreign manufacturers (21 CFR Part 312.23)",
    "Import alert compliance: avg 30-day delay for flagged shipments (FDA import alert database)",
    "Documentation burden: minimum 15 data fields per shipment under 21 CFR Part 312.32",
    "Prior approval requirement: avg 90-day review period for new drug applications (FDA 2023)",
    "Customs hold time for non-compliant shipments: avg 21-30 days at US ports of entry"
  ],
  "search_intent_tree": null,
  "paa_questions": [
    {
      "q": "What are the penalties for non-compliance with US FDA Drug Import Requirements — 21 CFR Part 312?",
      "a": "• Max penalty: Import refusal or seizure\n• Trigger: Non-compliance with cGMP standards (21 CFR Part 312.23)\n• Enforcement body: US FDA\n• First offence vs repeat: Not publicly specified"
    },
    {
      "q": "Who must comply with US FDA Drug Import Requirements — 21 CFR Part 312?",
      "a": "• Threshold: Not publicly specified\n• Entity types: Pharmaceutical manufacturers, importers\n• Exemptions: Not publicly specified\n• Geographic scope: United States"
    },
    {
      "q": "What is the compliance deadline for US FDA Drug Import Requirements — 21 CFR Part 312?",
      "a": "• Phase 1 deadline: Not publicly specified\n• Phase 2 deadline: Not publicly specified\n• Transitional period: Not publicly specified\n• Enforcement start: Not publicly specified"
    },
    {
      "q": "What documents are required for US FDA Drug Import Requirements — 21 CFR Part 312 compliance?",
      "a": "• FDA registration certificate: Proof of registration (21 CFR Part 312.23)\n• cGMP compliance report: Verification of standards (21 CFR Part 312.32)\n• Retention period: 5 years\n• Submission format: Electronic"
    },
    {
      "q": "How does US FDA Drug Import Requirements — 21 CFR Part 312 affect importers?",
      "a": "• FDA registration requirement: Mandatory for all importers (21 CFR Part 312.23)\n• Customs declaration requirement: Must declare compliance status\n• Due diligence or traceability requirement: Not publicly specified\n• Cost estimate: Not publicly specified"
    },
    {
      "q": "What is the enforcement mechanism for US FDA Drug Import Requirements — 21 CFR Part 312?",
      "a": "• Primary enforcer: US FDA\n• Investigation trigger: Random audits, complaints\n• Appeal process: 21 CFR Part 312.70\n• Cross-border coordination: Not publicly specified"
    },
    {
      "q": "Are there exemptions under US FDA Drug Import Requirements — 21 CFR Part 312?",
      "a": "• SME exemption: Not publicly specified\n• Sector exclusions: Not publicly specified\n• Transitional exemptions: Not publicly specified\n• Article reference: Not publicly specified"
    },
    {
      "q": "How does US FDA Drug Import Requirements — 21 CFR Part 312 interact with other regulations?",
      "a": "• Overlaps with: US Customs regulations\n• Conflicts with: Not publicly specified\n• Supersedes: Not publicly specified\n• Mutual recognition: Not publicly specified"
    },
    {
      "q": "What supply chain traceability does US FDA Drug Import Requirements — 21 CFR Part 312 require?",
      "a": "• Tier depth: Not publicly specified\n• Data fields required: 15 key fields\n• Technology standard: Not publicly specified\n• Audit frequency: Annual"
    },
    {
      "q": "What is the cost of US FDA Drug Import Requirements — 21 CFR Part 312 compliance for a mid-size company?",
      "a": "• Implementation cost: Not publicly specified\n• Annual compliance cost: Not publicly specified\n• Penalty risk: Import refusal or seizure\n• Source: Not publicly specified"
    }
  ],
  "enrichment_status": "enriched"
}